Thrive Wealth Management’s Equifax EFX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$209K Sell
1,315
-582
-31% -$99.2K 0.03% 244
2026
Q1
$342K Sell
1,897
-1,010
-35% -$201K 0.05% 158
2025
Q4
$631K Sell
2,907
-56
-2% -$12.3K 0.09% 109
2025
Q3
$760K Buy
2,963
+834
+39% +$210K 0.11% 98
2025
Q2
$552K Buy
2,129
+822
+63% +$209K 0.09% 115
2025
Q1
$318K Buy
1,307
+121
+10% +$30.4K 0.06% 153
2024
Q4
$302K Sell
1,186
-27
-2% -$7.24K 0.05% 154
2024
Q3
$356K Sell
1,213
-13
-1% -$3.67K 0.07% 151
2024
Q2
$297K Buy
1,226
+124
+11% +$29.6K 0.06% 161
2024
Q1
$295K Buy
1,102
+89
+9% +$22.6K 0.06% 160
2023
Q4
$251K Buy
+1,013
New +$205K 0.06% 163
2023
Q3
Sell
-987
Closed -$232K 172
2023
Q2
$232K Buy
+987
New +$208K 0.06% 159

Other funds holding EFX

Thrive Wealth Management's EFX Position: Q2 2026 in Review

Thrive Wealth Management reduced its Equifax (EFX) stake by 31% in Q2 2026, selling an estimated $99.2K and leaving 1,315 shares worth $209K. The position accounts for 0.03% of the portfolio, ranked #244.

Thrive Wealth Management first reported a position in EFX in Q2 2023 and has held it in 12 quarters since. The position peaked at $760K in Q3 2025. 94 funds tracked by Wall St. Rank hold EFX as of Q2 2026.

  • Thrive Wealth Management held 1,315 shares of Equifax worth $209K as of Q2 2026.
  • Thrive Wealth Management sold 582 Equifax shares in Q2 2026, an estimated $99.2K.
  • Equifax made up 0.03% of Thrive Wealth Management's portfolio in Q2 2026, its #244 holding.
  • Thrive Wealth Management first reported a position in Equifax in Q2 2023 and has held it in 12 quarters since.
  • Thrive Wealth Management's Equifax position peaked at $760K in Q3 2025.
  • 94 funds tracked by Wall St. Rank held Equifax as of Q2 2026.

Based on Thrive Wealth Management's 13F filing for Q2 2026, filed 7 Jul 2026.